| Date | Event | Reminder | | No Upcoming Events |
|
| Date | Event | | 24-Nov-09 | OREXIGEN THERAPEUTICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and E | | 5-Nov-09 | OREXIGEN THERAPEUTICS, INC. Files SEC form 10-Q, Quarterly Report | | 4-Nov-09 | Orexigen Therapeutics, Inc. Earnings Call scheduled for 5:00 pm ET today | | 4-Nov-09 | OREXIGEN THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Change in Directors or | | 4-Nov-09 | Earnings announcement | | 1-Oct-09 | OREXIGEN THERAPEUTICS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits | | 30-Sep-09 | Orexigen Therapeutics Empatic Phase 2B Results Call scheduled for 8:30 am ET today | | 30-Sep-09 | OREXIGEN THERAPEUTICS, INC. Files SEC form 8-K, Regulation FD Disclosure, Other Events, Financial Statements and Exhi | | 21-Sep-09 | Price hit new 52-week high ($10.83) | | 10-Sep-09 | Price hit new 52-week high ($9.67) | | 7-Aug-09 | OREXIGEN THERAPEUTICS, INC. Files SEC form 10-Q, Quarterly Report | | 6-Aug-09 | OREXIGEN THERAPEUTICS INC Earnings Call scheduled for 5:00 pm ET today | | 6-Aug-09 | OREXIGEN THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements a | | 27-Jul-09 | OREXIGEN THERAPEUTICS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits | | 22-Jul-09 | Price hit new 52-week high ($9.47) | | 20-Jul-09 | OREXIGEN THERAPEUTICS, INC. Files SEC form 8-K, Regulation FD Disclosure, Other Events, Financial Statements and Exhi | | 11-Jun-09 | OREXIGEN THERAPEUTICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement | | 2-Jun-09 | OREXIGEN THERAPEUTICS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits | | 8-May-09 | OREXIGEN THERAPEUTICS, INC. Files SEC form 10-Q, Quarterly Report | | 7-May-09 | OREXIGEN THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements a | | 29-Apr-09 | OREXIGEN THERAPEUTICS, INC. Files SEC form 8-K/A, Change in Directors or Principal Officers | | 1-Apr-09 | OREXIGEN THERAPEUTICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and E | | 13-Mar-09 | OREXIGEN THERAPEUTICS, INC. Files SEC form 10-K, Annual Report | | 12-Mar-09 | OREXIGEN THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements a | | 2-Mar-09 | OREXIGEN THERAPEUTICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and E | | 4-Feb-09 | OREXIGEN THERAPEUTICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement | | 29-Jan-09 | OREXIGEN THERAPEUTICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers | | 9-Jan-09 | OREXIGEN THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosu | | 5-Dec-08 | OREXIGEN THERAPEUTICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and E | | 5-Dec-08 | Price hit new 52-week low ($1.55) | | 10-Nov-08 | OREXIGEN THERAPEUTICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and E | | 7-Nov-08 | OREXIGEN THERAPEUTICS, INC. Files SEC form 10-Q, Quarterly Report | | 6-Nov-08 | OREXIGEN THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements a |
|
| |
|
1.48% Nasdaq 
Company Events
